Edition:
India

Melinta Therapeutics Inc - Reaffirms Product Sales And Cost Savings Guidance


Wednesday, 19 Dec 2018 

Melinta Therapeutics Inc ::MELINTA THERAPEUTICS ANNOUNCES COMMITMENT FOR NEW CREDIT FACILITY OF UP TO $135 MILLION.MELINTA THERAPEUTICS INC SAYS ADJOURNED ITS SPECIAL MEETING OF STOCKHOLDERS SCHEDULED FOR DECEMBER 20, 2018 TO A DATE TO BE DETERMINED LATER.MELINTA THERAPEUTICS INC - REAFFIRMS PRODUCT SALES AND COST SAVINGS GUIDANCE.MELINTA THERAPEUTICS INC - CREDIT FACILITY HAS OPTION TO BE CONVERTED INTO PREFERRED SHARES.MELINTA THERAPEUTICS INC - BELIEVE NEW CREDIT FACILITY FROM VATERA WILL TAKE CO TO APPROACHING CASH FLOW BREAKEVEN.MELINTA THERAPEUTICS INC - ONCE COMPLETED, CONFIDENT CASH INFUSION WILL PROVIDE CO WITH LIQUIDITY TO FUND BUSINESS WELL INTO 2020.MELINTA THERAPEUTICS INC - UPON EXECUTION, FINAL LOAN AGREEMENT WILL REPLACE PREVIOUSLY ANNOUNCED PURCHASE AGREEMENT BETWEEN MELINTA AND VATERA. 

Company Quote

4.04
0.06 +1.51%
12:31am IST